Speakers
Ed Ha
Head of Chemistry & Bioconjugation
Angiex
Day Two
Thursday 1st July 2021
2:05 pm | Live Presenter Q&A
2:15 pm | Panel Discussion: Small Molecule vs Biologics in Induced Proximity
1:40 pm | How ADC Hunters Investigate Induced Proximity
Nancy Pryer
Chief Scientific Officer
Ambagon Therapeutics
Day One
Wednesday 30th June 2021
9:00 am | Panel Discussion: Advancing the Discovery of Proximity-Based Medicines
Ryan Potts
Executive Director & Head of Induced Proximity Platform
Amgen
Day Two
Thursday 1st July 2021
2:15 pm | Panel Discussion: Small Molecule vs Biologics in Induced Proximity
Derek J. Taylor
Associate Professor
Case Western Reserve University
Benjamin Stanton
Principal Investigator
Abigail Wexner Research Institute at Nationwide Children’s Hospital
Day One
Wednesday 30th June 2021
12:20 pm | Live Presenter Q&A
11:30 am | Chemically Induced Proximity in Biology and Medicine
Stuart L. Schreiber
Co-Founder
Broad Institute
Day One
Wednesday 30th June 2021
10:00 am | 30 Years of Molecular Glues: Controlling Cell Circuitry in Biology and Medicine
Katelyn Cassidy
Senior Scientist
AstraZeneca
Eric Wang
Research Fellow
Dana-Farber Cancer Institute
Day Two
Thursday 1st July 2021
5:35 pm | Live Presenter Q&A
5:10 pm | Structure Based Design of Degraders
Radoslaw Nowak
Scientist
Dana-Farber Cancer Institute
Day Two
Thursday 1st July 2021
5:35 pm | Live Presenter Q&A
5:10 pm | Structure Based Design of Degraders
Charles Lin
Senior Vice President – Biology
Kronos Bio
Day One
Wednesday 30th June 2021
9:00 am | Panel Discussion: Advancing the Discovery of Proximity-Based Medicines
Jamie Kasuboski
Vice President
OMX Ventures
Day One
Wednesday 30th June 2021
12:20 pm | Live Presenter Q&A
11:55 am | Induced Proximity: An Investors Perspective
Cristina Mayor- Ruiz
Group Leader
IRB Barcelona
Day One
Wednesday 30th June 2021
2:45 pm | Live Presenter Q&A
1:40 pm | Strategies to Discover Molecular Glue Degraders at Scale
Jonathan Solomon
Associate Director
Novartis Institutes for Biomedical Research
Day Two
Thursday 1st July 2021
11:25 am | Discovery of a VHL-binding Molecular Glue Degrader
11:50 am | Live Presenter Q&A
Matthias Brand
VP Biology
Proxygen
Day One
Wednesday 30th June 2021
2:45 pm | Live Presenter Q&A
2:05 pm | Scalable Discovery and Streamlined Characterization of Novel Molecular Glue Degraders
Chad May
Senior Vice President, R&D
Maverick Therapeutics
Day Two
Thursday 1st July 2021
2:05 pm | Live Presenter Q&A
2:15 pm | Panel Discussion: Small Molecule vs Biologics in Induced Proximity
1:15 pm | Bispecific T Cell Engagers Designed to Redirect Effector Function
Goutham Narla
Professor of Medicine
University of Michigan
Day Two
Thursday 1st July 2021
11:50 am | Live Presenter Q&A
11:00 am | Biased and Selective Small Molecule Mediated Activation of Protein Phosphatase 2A
Daniel Nomura
Professor of Chemical Biology
University of California, Berkeley
Day One
Wednesday 30th June 2021
4:35 pm | Live Presenter Q&A
3:20 pm | Reimagining Druggability using Chemoproteomic Platforms
Kevin Foley
Chief Scientific Officer
Ranok Therapeutics Co. Ltd.
Day One
Wednesday 30th June 2021
9:00 am | Panel Discussion: Advancing the Discovery of Proximity-Based Medicines
12:20 pm | Live Presenter Q&A
8:50 am | Chair’s Opening Remarks
Day Two
Thursday 1st July 2021
9:50 am | Live Presenter Q&A
9:25 am | Tumor-Targeted Protein Degradation Mediated by Cellular Chaperones
Fleur Ferguson
Assistant Professor
University of California, San Diego
Day One
Wednesday 30th June 2021
4:35 pm | Live Presenter Q&A
3:45 pm | Chemoproteomic Approaches to Interrogate the Degradable Kinome
George Burslem
Assistant Professor
University of Pennsylvania
Day Two
Thursday 1st July 2021
4:20 pm | Live Presenter Q&A
3:30 pm | Chemical Approaches for Modulating Lysine Post-Translational Modifications: Ubiquitin and Beyond
Ivan Dikic
Director of Institute of Biochemistry II
Goethe University Frankfurst
Day Two
Thursday 1st July 2021
9:00 am | Future Challenges in the Proximity-Inducing Drugs (ProxiDrugs) Field
9:50 am | Live Presenter Q&A
Katherine Donovan
Senior Scientist
Dana-Farber Cancer Institute
Day One
Wednesday 30th June 2021
9:00 am | Panel Discussion: Advancing the Discovery of Proximity-Based Medicines
Christian Ottmann
Chief Technology Officer
Ambagon Therapeutics
Day Two
Thursday 1st July 2021
4:45 pm | Small-Molecule Stabilization of 14-3-3 Protein-Protein Interactions
5:35 pm | Live Presenter Q&A
Amit Chouhdary
Assistant Professor
Broad Institute, Harvard Medical School & Brigham and Women’s Hospital
Day Two
Thursday 1st July 2021
4:20 pm | Live Presenter Q&A
Ashley Modell
Postdoctoral Researcher, Choudhary Lab
Broad Institute of MIT and Harvard, and Harvard Medical School
Day Two
Thursday 1st July 2021
4:20 pm | Live Presenter Q&A
3:55 pm | Rewiring Kinases Using Bifunctional Molecules
Carla Gauss
Senior Application Scientist, Medicinal Chemist
Nanome
Day One
Wednesday 30th June 2021
2:30 pm | Designed Degraders of PCSK9 in Nanome
2:45 pm | Live Presenter Q&A
Dirksen E. Bussiere
Sr. Director, Molecular Pharmacology
Eli Lilly and Company
Day One
Wednesday 30th June 2021
4:10 pm | The Structural Basis of Indisulam-Mediated Recruitment of RBM39 to the DCAF15-DDB1-DDA1 E3 Ligase Complex
4:35 pm | Live Presenter Q&A
Danette Daniels
Group Leader - Functional Proteomics
Promega
William Marsiglia
PostDoc
Icahn School of Medicine at Mount Sinai